Viewing Opinion | StockChase
stockchase picture

Compiling comments that experts make about stocks while on public TV.

2017-09-12

Opinion for Teva Pharmaceutical (TEVA-N)

Signal Price Bias Subject Owned
SELL $19.330 BEARISH on CANADIAN MARKET US EQUITIES Unknown

There is a long road for new management. A lot to do and very significant fundamental risks. There are a number of well-flagged horrendously long list of knocks against the company right now. It has recently had a nice upswing, so if you own it, lock it in and walk away.

Cameron Hurst
Chief Investment Officer, Equium Capital Management

No Comments.


You must be logged in to comment.